Credit: Matt Miller/WashU Medicine
A small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Shown, William E. Gillanders, MD, (right) and Xiuli Zhang, MD, examine blood test results indicating study participants' responses to the vaccine. The early-stage trial indicated that the treatment is safe and elicits immune responses.